Raymond Chan, Head of Asian Desk at Morgans, is again a fan of Resmed (RMD). In our “HOT STOCK” column today, Raymond goes through the reasons why he continues to believe RMD is an ADD to an inves..

Anecdotal evidence from many tourism operators points to Aussie travellers rethinking travel plans to travel at home – where the Australian dollar will always be an Australian dollar. Here are two p..

While this precious metal rally may have further to run, some profit-taking is prudent, but hear me out why I say this.

In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains why he expects Pinnacle Investment (PNI) to rally higher from here.

There are pockets of value still to be mined in the sector. Here are two mid-tier gold producers that fit the bill very nicely.

Here’s an undervalued Listed Investment Company (LIC) to consider, and another idea for the watchlist.

In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, says that with China banning the exports of rare earths to the US, Lynas Rare Earths (LYC) is a buy again.

In our “HOT STOCK” column today, Raymond Chan, Head of Asian Desk, gives us a rundown on what tariffs apply to various pharma stocks and which pharma he sees as an ADD to an investor’s portfolio..

The outlook for CSL (one of the few true global leaders on the ASX) from the analysts (who aren’t always right) is that the recent price decline gives investors an improved access point to a high-qu..

So far so good with the Trump U-turn on tariffs, but uncertainty still prevails. Is cautious buying to take advantage of lower valuations therefore warranted?